Atrogi Alexandra Ekman Ryding

Tue, Mar 22, 2022 08:00 CET

Medium resolution

Original resolution

Subscribe

Related Releases

Atrogi announces first patient treated with its ATR-258 ß\2\ adrenoceptor agonist in a phase I clinical study for the treatment of type 2 diabetes Wed, Jan 25, 2023 08:30 CET